Simplify Logo

Full-Time

Brand Manager

Filler Marketing

Posted on 6/25/2024

Revance

Revance

501-1,000 employees

Biotechnology company for aesthetic solutions

Fintech
Biotechnology
Healthcare

Compensation Overview

$102.5k - $140.9kAnnually

+ 401k match + ESPP program + Tuition Reimbursement + Wellness Discounts

Junior

Nashville, TN, USA

Hybrid option available from Nashville, TN.

Category
Brand & Creative Marketing
Growth & Marketing
Required Skills
Market Research
Marketing
Data Analysis
Requirements
  • Master’s degree or Bachelor’s Degree with related experience
  • Bachelor’s degree in marketing or advertising
  • 5+ years of professional marketing experience
  • Experience in pharmaceutical, device, bio-tech, or aesthetics industry
  • Strong project management skills
  • Ability to work collaboratively with multiple stakeholders
  • Entrepreneurial spirit and ability to work in a fast-paced environment
  • Creative and strategic thinker
  • Proven ability to multitask and meet deadlines
  • Exceptional verbal and written communication skills
  • Experience with promotional review process
Responsibilities
  • Develop and manage professional marketing plans
  • Collaborate with internal and external parties for initiative success
  • Lead projects and coordinate with cross-functional team members
  • Execute downstream marketing initiatives
  • Complete and implement brand plan and key initiatives
  • Lead competitive intelligence tracking and reporting
  • Act as central point of contact to the field
  • Participate in market research and lead analytics

Revance Therapeutics, Inc. specializes in aesthetic and therapeutic solutions, primarily focusing on products that enhance physical appearance and improve patient outcomes. The company offers neuromodulators, like botulinum toxin type A, which reduce wrinkles and treat muscle movement disorders, and dermal fillers that restore volume and smooth facial lines. Revance is also exploring therapeutic uses for its products in muscle movement and pain disorders. Additionally, the company has expanded into the fintech sector with the acquisition of HintMD, a platform that streamlines payment processes for aesthetic practices. This integration allows Revance to provide a comprehensive suite of services to support aesthetic practitioners. Unlike its competitors, Revance emphasizes differentiated products and improved patient experiences, aiming to establish itself as a leader in the premium aesthetics market.

Company Stage

IPO

Total Funding

$1.8B

Headquarters

Nashville, Tennessee

Founded

1999

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

-11%

2 year growth

9%
Simplify Jobs

Simplify's Take

What believers are saying

  • Revance's partnership with Viatris to commercialize DAXXIFY in China opens up significant international market opportunities.
  • The launch of DAXXIFY for cervical dystonia treatment positions Revance as a key player in the U.S. therapeutics neurotoxin market.
  • The company's $100 million public offering indicates strong investor confidence and provides capital for further expansion and innovation.

What critics are saying

  • The biotech and aesthetics markets are highly competitive, requiring continuous innovation to maintain market share.
  • Regulatory hurdles and FDA approvals can delay product launches and impact revenue streams.

What makes Revance unique

  • Revance's integration of fintech solutions like HintMD into its aesthetic offerings provides a unique value proposition that competitors in the biotech space lack.
  • The company's focus on both aesthetic and therapeutic applications for neuromodulators and dermal fillers sets it apart from competitors who may focus solely on one area.
  • Revance's recent launch of DAXXIFY for cervical dystonia treatment highlights its commitment to expanding into therapeutic markets, differentiating it from purely aesthetic-focused companies.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE